Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sensitive RIA for the specific determination of insulin lispro

R R Bowsher1, R A Lynch, P Brown-Augsburger

  • 1Department of Drug Disposition, Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, IN 46285, USA. bowsher_ronald_r@lilly.com

Clinical Chemistry
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Partial budget analysis of culture- and algorithm-guided selective dry cow therapy.

Journal of dairy science·2021
Same author

Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain.

Osteoarthritis and cartilage·2014
Same author

Urinary desmosine as a biomarker in acute lung injury.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2006
Same author

Graphical human insulin time-activity profiles using standardized definitions.

Diabetes technology & therapeutics·2002
Same author

Increased myocardial Rab GTPase expression: a consequence and cause of cardiomyopathy.

Circulation research·2001
Same author

Workshop on bioanalytical methods validation for macromolecules: summary report.

Pharmaceutical research·2001

A new assay can now specifically measure insulin lispro, an insulin analog, even when natural insulin is present. This breakthrough allows for more precise monitoring of insulin lispro levels in patients.

Area of Science:

  • Biochemistry
  • Immunology
  • Endocrinology

Background:

  • Insulin lispro, an altered insulin analog, shares high homology with endogenous insulin, hindering specific measurement.
  • Accurate quantification of insulin lispro offers clinical advantages over total immunoreactive insulin measurements.

Purpose of the Study:

  • To develop a specific and sensitive assay for quantifying insulin lispro in serum.
  • To overcome the challenge of distinguishing insulin lispro from endogenous insulin.

Main Methods:

  • Development of a novel immunoadsorption strategy using despentapeptide insulin to create a monospecific antiserum.
  • Utilization of the specific antiserum in a competitive radioimmunoassay (RIA) for insulin lispro.

Main Results:

Related Experiment Videos

  • The developed RIA demonstrated a low limit of quantification (17.2 pmol/L).
  • The assay showed no interference from insulin, proinsulin, or C-peptide.
  • High precision was observed with interassay coefficients of variation (CVs) ranging from 2.6% to 13.4%.

Conclusions:

  • A novel competitive RIA has been successfully developed for the specific determination of insulin lispro.
  • This assay is suitable for measuring serum insulin lispro concentrations, offering improved specificity compared to existing methods.